| 讲座 |
|
|
|
|
| 移植细胞的种类及其有效性和安全性——细胞移植治疗连载之二 |
| 王佃亮 |
| 第二炮兵总医院药学部 北京 100088 |
|
| The Types, Safety and Efficacity of the Transplanted Cells |
| WANG Dian-liang |
| Department of Pharmacy, The Second Artillery General Hospital, Beijing 100088, China |
[1] Liau B, Zhang D, Bursac N. Functional cardiac tissue engineering. Regen Med, 2012,7(2):187-206.
[2] Lipinski M J, Biondi-Zoccai G G, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol, 2007,50:1761.
[3] Silva E A, Kim E S, Kong H J,et al. Material-based deployment enhances efficacy of endothelial progenitor cells. PNAS, 2008,105:14347-14352.
[4] Li X D, Xu B, Wu J, et al. Review of chinese clinical trials on CIK cell treatment for malignancies. Clin Transl Oncol,2012,14(2):102-108.
[5] Nehls V, Herrmann R, Huhnken M. Guided migration as a novel mechanism of capillary network remodeling is regulated by basic fibroblast growth factor. Histochem Cell Biol,1998,109:319-329.
[6] Simmoneau G, Robbins I M, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2009,54:S43-54.
[7] Lei Z, Yongda L, Jun M, et al. Culture and neural differentiation of rat bone marrow mesenchymal stem cells in vitro. Cell Biol Int, 2007,31:916-923.
[8] Russ H A, Efrat S. Development of human insulin-producing cells for cell therapy of diabetes. Pediatr Endocrinol Rev, 2011,9(2):590-597.
[9] Coopman K. Large-scale compatible methods for the preservation of human embryonic stem cells: current perspectives. Biotechnol Prog, 2011, 27(6):1511-1521.
[10] Meyer G P,Wollert K C, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months’follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration)trial. Circulation, 2006,113:1287.
[11] Noce C W, Gomes A, Copello A, et al. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent, 2011,59(6):458-462.
[12] Nuri M M, Hafeez S. Autologous bone marrow stem cell transplant in acute myocardial infarction. J Pak Med Assoc. 2012,62(1):2-6.
[13] Patel B B, Majumdar A P. Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutr. Cancer, 2009,61(6):842-846.
[14] Quevedo H C, Hatzistergos K E, Oskouei B N, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA, 2009,106:14022-14027.
[15] Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med,2006,355:1210-1221.
[16] Sekiguchi H, Li M, Losordo D W. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol, 2009,219:235-242.
[17] Kim Y S, Ahn Y. A long road for stem cells to cure sick hearts: update on recent clinical trials. Korean Circ J, 2012,42(2):71-79. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
